Katsuta, E., Yan, L., Opyrchal, M., Kalinski, P., & Takabe, K. (2021). Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer. Ther Adv Med Oncol.
Citação norma ChicagoKatsuta, Eriko, Li Yan, Mateusz Opyrchal, Pawel Kalinski, and Kazuaki Takabe. "Cytotoxic T-lymphocyte Infiltration and Chemokine Predict Long-term Patient Survival Independently of Tumor Mutational Burden in Triple-negative Breast Cancer." Ther Adv Med Oncol 2021.
Citação norma MLAKatsuta, Eriko, et al. "Cytotoxic T-lymphocyte Infiltration and Chemokine Predict Long-term Patient Survival Independently of Tumor Mutational Burden in Triple-negative Breast Cancer." Ther Adv Med Oncol 2021.